18 Sept 2025 Thermo Fisher obtains clearance for its $4.1 billion acquisition of Solventum’s Purification and Filtration Business Healthcare & Life Sciences
16 Sept 2025 Compass Lexecon advises Energie Nederland on Resource Adequacy and the future design of the Dutch electricity market Energy
11 Sept 2025 Compass Lexecon Affiliate Professor B. Douglas Bernheim Testifies Successfully in Amex Antitrust Jury Trial Financial Institutions & Products
Insights Healthcare & Life Sciences Search Search insight Filters Type Type… News Publications Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Antitrust & Competition: Damages Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences Healthcare & Life Sciences Clear all Showing 1–4 of 4 results News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry Article • 05 Dec 2011 The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients
News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients